Ryvu Therapeutics (WAR:RVU) Buildings And Improvements : zł0.00 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics Buildings And Improvements?

Ryvu Therapeutics's quarterly buildings and improvements increased from Sep. 2024 (zł0.00 Mil) to Dec. 2024 (zł54.83 Mil) but then declined from Dec. 2024 (zł54.83 Mil) to Mar. 2025 (zł0.00 Mil).

Ryvu Therapeutics's annual buildings and improvements increased from Dec. 2022 (zł54.68 Mil) to Dec. 2023 (zł54.81 Mil) and increased from Dec. 2023 (zł54.81 Mil) to Dec. 2024 (zł54.83 Mil).

Ryvu Therapeutics Buildings And Improvements Historical Data

The historical data trend for Ryvu Therapeutics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryvu Therapeutics Buildings And Improvements Chart

Ryvu Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

52.59

55.68

54.68

54.81

54.83

Ryvu Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	54.83	-

Ryvu Therapeutics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Ryvu Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

9Y4:Germany

Address

Leona Henryka Sternbacha 2, Krakow, POL, 30-394

Website

https://www.ryvu.com

Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics Headlines

No Headlines